Background paper to the recommendation for routine rotavirus vaccination of infants in Germany

被引:25
作者
Koch, J. [1 ]
Wiese-Posselt, M. [1 ]
Remschmidt, C. [1 ]
Wichmann, O. [1 ]
Bertelsmann, H. [2 ]
Garbe, E. [3 ]
Hengel, H. [4 ]
Meerpohl, J. J. [5 ]
Marques, A. Mas [6 ]
Oppermann, H. [7 ]
Hummers-Pradier, E. [8 ]
von Kries, R. [9 ]
Mertens, T. [10 ]
机构
[1] Robert Koch Inst, Immunizat Unit, D-13086 Berlin, Germany
[2] Univ Appl Sci, Fachhsch Diakonie, Bielefeld, Germany
[3] Univ Bremen, Bremen Inst Prevent Res & Social Med, D-28359 Bremen, Germany
[4] Univ Med Ctr Freiburg, Dept Virol, Inst Med Microbiol & Hyg, Freiburg, Germany
[5] Univ Med Ctr Freiburg, Inst Med Biometry & Med Informat, German Cochrane Ctr, Freiburg, Germany
[6] Robert Koch Inst, Div Viral Gastroenteritis & Hepatitis Pathogens &, Berlin, Germany
[7] State Off Consumer Protect, Magdeburg, Germany
[8] Univ Gottingen, Univ Med Ctr Goettingen, Dept Gen Practice Family Med, D-37073 Gottingen, Germany
[9] Univ Munich, Inst Social Paediat & Adolescent Med, Munich, Germany
[10] Univ Ulm, Med Ctr, Inst Virol, D-89069 Ulm, Germany
关键词
Rotavirus vaccination; Rotavirus gastroenteritis; Vaccination recommendation; Standing committee on vaccination (STIKO); Germany; 1ST; 2; YEARS; GROUP-A; ACUTE GASTROENTERITIS; UNITED-STATES; CHILDHOOD DIARRHEA; KAWASAKI-DISEASE; EUROPEAN INFANTS; CONCOMITANT USE; ADVERSE EVENTS; YOUNG-CHILDREN;
D O I
10.1007/s00103-013-1777-3
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Two rotavirus (RV) vaccines were introduced to the European market in 2006. To support the decision-making process of the German Standing Committee on Vaccination ("Standige Impfkommission", STIKO) regarding adoption of routine RV vaccination into the national vaccination schedule in Germany relevant scientific background was reviewed. According to STIKO's Standard Operating Procedures for the development of evidence-based vaccination recommendations, a set of key questions was addressed and systematic reviews were performed with a focus on the efficacy, effectiveness, impact and safety of RV vaccines. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology was applied to assess the quality of available evidence. Data from 5 randomized controlled trials demonstrated a high efficacy of RV vaccines in preventing severe RV-associated gastroenteritis (91%) and hospitalization (92%) in settings comparable to Germany. Post-marketing observational studies confirmed these findings. In several countries, impact studies suggest that age groups not eligible for vaccination might also benefit from herd effects and demonstrated a decrease in the number of nosocomial RV infections after RV vaccine introduction. The vaccines were considered safe, except for a slightly increased risk of intussusception shortly after the first dose, corresponding to 1-2 additional cases per 100,000 infants vaccinated (relative risk = 1.21, 95% confidence interval [CI] 0.68-2.14). RV case-fatality is extremely low in Germany. However, RV incidence among children aged <5 years is high (reported 8-14 cases per 1000 children annually), and of these almost half require hositalization. In view of the available evidence and expected benefits, STIKO recommends routine rotavirus vaccination of children under the age of 6 months with the main goal of preventing RV-associated hospitalizations in Germany, especially among infants and young children.
引用
收藏
页码:957 / 984
页数:28
相关论文
共 182 条
[1]   Whole genome characterization of new bovine rotavirus G21P[29] and G24P[33] strains provides evidence for interspecies transmission [J].
Abe, Masako ;
Ito, Naoto ;
Masatani, Tatsunori ;
Nakagawa, Keisuke ;
Yamaoka, Satoko ;
Kanamaru, Yoshihiro ;
Suzuki, Hiroto ;
Shibano, Ken-ichi ;
Arashi, Yasuhiro ;
Sugiyama, Makoto .
JOURNAL OF GENERAL VIROLOGY, 2011, 92 :952-960
[2]   Rotavirus Vaccine Effectiveness and Case-control Study on Risk Factors for Breakthrough Infections in Germany, 2010-2011 [J].
Adlhoch, Cornelia ;
Hoehne, Marina ;
Littmann, Martina ;
Marques, Andreas Mas ;
Lerche, Almuth ;
Dehnert, Manuel ;
Eckmanns, Tim ;
Wichmann, Ole ;
Koch, Judith .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2013, 32 (02) :E82-E89
[3]   Rotavirus and not age determines gastroenteritis severity in children: a hospital-based study [J].
Albano, Fabio ;
Bruzzese, Eugenia ;
Bella, Antonino ;
Cascio, Antonio ;
Titone, Lucina ;
Arista, Serenella ;
Izzi, Giancarlo ;
Virdis, Raffaele ;
Pecco, Paola ;
Principi, Nicola ;
Fontana, Massimo ;
Guarino, Alfredo .
EUROPEAN JOURNAL OF PEDIATRICS, 2007, 166 (03) :241-247
[4]   Rotavirus vaccines: viral shedding and risk of transmission [J].
Anderson, Evan J. .
LANCET INFECTIOUS DISEASES, 2008, 8 (10) :642-649
[5]   Impact of Rotavirus Vaccination on Hospital-Acquired Rotavirus Gastroenteritis in Children [J].
Anderson, Evan J. ;
Rupp, Angela ;
Shulman, Stanford T. ;
Wang, Deli ;
Zheng, Xiaotian ;
Noskin, Gary A. .
PEDIATRICS, 2011, 127 (02) :E264-E270
[6]  
Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P687
[7]  
[Anonymous], 2009, Wkly Epidemiol Rec, V84, P220
[8]  
[Anonymous], 2011, PEDIATRICS, DOI DOI 10.1542/peds.2010-3722
[9]  
[Anonymous], ARCH VIROL
[10]  
[Anonymous], ROTAVIRUS VACCINATIO